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In present study, we aimed to identify and evaluate the trends of the 100 most-cited research 
articles on Covid-19 using bibliometric techniques. 
Methods 
Scopus online database hosted by Elsevier was used to extract relevant articles for this study. We 
have identified the top 100 research papers on Covid-19 published across the globe based on 
their citations data. Further analysis was made to find the countries of origin, journal wise 
distribution, author cluster network, keyword analysis and inter-citation map to understand and 
to establish the links among them. 
Results 
The T100 most cited articles were published between January-August, 2020 and their citations 
ranged from 304 to 5295. The T100 articles were contributed by 24 countries, with more than 
half is originated from China (n=63). Scientific publications originated from china received 
highest citations (55,688) followed by USA (13,996) and Hong Kong (9,501). Although ‘New 
England Journal of Medicine’ published the most papers (n=15) with the highest impact factor 
value of (74.699) but studies published in ‘The Lancet’ has received highest citations 
(n=18,431). The top five journals hold 44% of these influential studies. The Tongji medical 
college, Huazhong University of science & technology, Wuhan, China is the top institution with 
the most T100 articles in the field of Covid-19. 
Conclusions 
We analyzed the 100 most-cited articles in the field of Covid-19. China and USA are the 
dominant countries in terms of the number of T100 articles, scientists and institutions.  Scientific 
publications originated from China also had the highest mean number of citations. The leading 
institutions with the most productive articles were Tongji medical college, Jin yin-tan hospital, 
Tsinghua university school of medicine (China) and University of North Carolina (US). The 
study authored by Huang C on “Clinical features of patients infected with 2019 novel 
coronavirus in Wuhan, China” has received maximum citations (5295). 
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Introduction 
Citations are the key indicators to measure the quality, authorship and influence of an 
individual paper (Aksnes et al., 2019). Citation analysis measures the scientific performances of 
literature at a relatively low financial cost (Garfield, 1979). Citations indicators are now widely 
accepted and broadly applied to evaluate most-cited articles in different research domain. 
Garfield publication entitled "Highly Cited Works in Mathematics" in 1973 considered as classic 
paper which has given a depth insight to evaluate the highly cited papers. Citations values of a 
scholarly communication are being used by researchers to position their research work 
(Mansourizadeh & Ahmad, 2011). Citation-based approaches can reveal the dynamics of 
scientific activities and conveys foresight into emerging trends (Chen & Song, 2019). The spread 
of COVID-19 virus has created unprecedented chaos and posed one of the greatest threats before 
the survival of the human race. The global scientific communities have responded to the crises 
and coordinated effort is made to containing the spread of this epidemic & provides optimal care 
to those affected by the disease (WHO, 2020). Research published on covid-19 in many 
scientific journals in very short periods has increased tremendously. As per Scopus database, 
there were 43,723 research documents published on coronavirus disease in just eight months into 
the outbreak of the epidemic (during 01 January to 31 August 2020). However, we found that 
there is a lack of comprehensive studies that provide an overall evaluation of the most-cited 
papers on Covid-19. The purpose of the present study was to identify the 100 most-cited articles 
on Covid-19 and to analyze their characteristics and inter-citation network. 
 
Literature Reviewed 
Coronavirus research publications trends are scattered and lie with many domains 
including medical science, management, tourism, psychology, sociology and many more. These 
studies mainly dealt with a wide variety of concerns like Covid-19 impact and effect on 
community health and its relations with various diseases like diabetes, hypertension (Parohan et 
al., 2020). Others domain studies are mainly concerned with COVID-19 impact on the industry, 
tourism, socio-economic conditions and its relationship with lockdown, closed border 
(Owojaiye; Lau et al.; Nikola et al., 2020). Research progress on Coronavirus and COVID-19 
significantly focused on virology, epidemiology, and infectious diseases among others. However, 
there seems to be gap in research areas related to public health, its governance, technology, and 
communication (Zhang & Shaw, 2020). The emergence of COVID-19 has had a significant 
impact in other fields, particularly the social science, technology, physical sciences and arts and 
sciences, not just among clinical professionals(medical science) (Ruiz-Real et al., 2020). 
Bibliometric studies on Coronavirus and Covid-19 mainly focused on citation pattern co-word or 
cluster studies or Visualization in general context (Nicola et al.; Shamsi et al.; Fonkou et al., 
2020). However, there are only a few bibliometric studies conducted so far at the global level in 
the context of both Coronavirus and Covid-19. The year 2020 is the witness of rapid scientific 
publications on Covid-19 (Sahoo & Pandey, 2020). Researches conducted on top-cited papers on 
Coronavirus are rare mainly published during 1973 to 2016 and appeared with the most 
prominent source like 'Journal of Virology' and from the USA. The University of Hong Kong 
became the most productive institute which published the most number of highly cited articles 
(Ram & Nisha, 2020). Study has co-related the evolving research pattern of both Coronavirus 
and Covid-19 and concluded that USA dominates in the research output, while most of the 
influential institutions are from China (Sahoo & Pandey, 2020). Top fifty cited papers on Covid-
19 appeared in most reputed journals. The main focus of these papers was clinical/radiological 
aspect of Covid-19 rather than treatments/vaccines (El Hawary, 2020).  
 Therefore, our study aimed at filling this knowledge gap by examining the global 
research trends on Covid-19 pandemic based on a bibliometric analysis of most-cited 100 articles 
in the year 2020.  The primary objectives of  our study are i) to identify the top 100 most-cited 
articles on COVID-19 ii) to identify the sources that published the 100 most-cited papers iii) to 
visualize the network of prominent authors based on their citations values iv) to analyze the 
characteristics and inter-citation network of these influential studies. 
 
Materials & Methods 
 SCOPUS online database hosted by Elsevier is used for this study. A well defined 
systematic approach was adopted to retrieve the top cited publications. The following structured 
search query was formulated and total of 43,723 published research documents were identified 
on  Covid-19 during 01 January to 31 August 2020. This search yielded 43,723 results, were then 
sorted in descending order with respect to the citations count.      
Search Query: ((TITLE-ABS-KEY(Covid-19) OR (Coronavirus) OR (Coronavirus disease 
2019) OR (SARS-COV-2) OR (2019-nCov)) AND PUBYEAR > 2019  AND ( EXCLUDE ( 
DOCTYPE,"er" ) )  
 
 The identified records were further refined and datasets were fixed based on their 
relevancy. Duplicate and irrelevant records & documents type such as ‘erratum’ has excluded 
from the sample data.  The final dataset of T100 most-cited articles was assessed and analyzed 
using VOSviewer tool (Van Eck & Waltman, 2010). Citations data for this study was obtained 
till 31 August 2020. The journals impact factor values were cross referenced with the 2020 
edition of Journal Citation Reports (JCR). Visualization maps were created for understanding the 
characters and influence of these studies.  
 
Results  
 The most influential manuscripts (T100) were identified out of 43,514 records retrieved 
from SCOPUS database. Table 1 shows the list of these most cited articles. The citations ranged 
from 304 for Xiao et al. (“Evidence for Gastrointestinal Infection of SARS-CoV-2”) to 5,295 for 
Huang et al. (“Clinical features of patients infected with 2019 novel coronavirus in Wuhan, 
China”). In total 75,747 number of citation received by these top 100 studies.  
Table 1. The top 100 most-cited papers on Covid-19 
Rank First Author Title Source title Citation 
Count 
1 Huang C. Clinical features of patients infected with 2019 novel 
coronavirus in Wuhan, China 
The Lancet 5295 
2 Guan W. Clinical characteristics of coronavirus disease 2019 in China New England Journal of Medicine 3407 
3 Wang D. Clinical Characteristics of 138 Hospitalized Patients with 2019 
Novel Coronavirus-Infected Pneumonia in Wuhan, China 
JAMA - Journal of the American 
Medical Association 
3162 
4 Zhu N. A novel coronavirus from patients with pneumonia in China, 
2019 
New England Journal of Medicine 2889 
5 Chen N. Epidemiological and clinical characteristics of 99 cases of 2019 
novel coronavirus pneumonia in Wuhan, China: a descriptive 
study 
The Lancet 2712 
6 Zhou F. Clinical course and risk factors for mortality of adult inpatients 
with COVID-19 in Wuhan, China: a retrospective cohort study 
The Lancet 2623 
7 Wu Z. Characteristics of and Important Lessons from the Coronavirus 
Disease 2019 (COVID-19) Outbreak in China: Summary of a 
Report of 72314 Cases from the Chinese Center for Disease 
Control and Prevention 
JAMA - Journal of the American 
Medical Association 
2051 
8 Zhou P. A pneumonia outbreak associated with a new coronavirus of 
probable bat origin 
Nature 2051 
9 Li Q. Early transmission dynamics in Wuhan, China, of novel 
coronavirus-infected pneumonia 
New England Journal of Medicine 2020 
10 Lu R. Genomic characterisation and epidemiology of 2019 novel 
coronavirus: implications for virus origins and receptor binding 
The Lancet 1465 
11 Chan J.F.-W. A familial cluster of pneumonia associated with the 2019 novel 
coronavirus indicating person-to-person transmission: a study 
of a family cluster 
The Lancet 1436 
12 Hoffmann M. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is 
Blocked by a Clinically Proven Protease Inhibitor 
Cell 1333 
13 Yang X. Clinical course and outcomes of critically ill patients with SARS-
CoV-2 pneumonia in Wuhan, China: a single-centered, 
retrospective, observational study 
The Lancet Respiratory Medicine 1195 
14 Xu Z. Pathological findings of COVID-19 associated with acute 
respiratory distress syndrome 
The Lancet Respiratory Medicine 1169 
15 Van 
Doremalen N. 
Aerosol and surface stability of SARS-CoV-2 as compared with 
SARS-CoV-1 
New England Journal of Medicine 1103 
16 Holshue M.L. First case of 2019 novel coronavirus in the United States New England Journal of Medicine 1087 
17 Wang M. Remdesivir and chloroquine effectively inhibit the recently 
emerged novel coronavirus (2019-nCoV) in vitro 
Cell Research 1063 
18 Mehta P. COVID-19: consider cytokine storm syndromes and 
immunosuppression 
The Lancet 1023 
19 Gautret P. Hydroxychloroquine and azithromycin as a treatment of 
COVID-19: results of an open-label non-randomized clinical 
trial 
International Journal of 
Antimicrobial Agents 
927 
20 Wu C. Risk Factors Associated with Acute Respiratory Distress 
Syndrome and Death in Patients with Coronavirus Disease 
2019 Pneumonia in Wuhan, China 
JAMA Internal Medicine 882 
21 Wu F. A new coronavirus associated with human respiratory disease 
in China 
Nature 872 
22 Cao B. A trial of lopinavir-ritonavir in adults hospitalized with severe 
covid-19 
New England Journal of Medicine 828 
23 Liang W. Cancer patients in SARS-CoV-2 infection: a nationwide analysis 
in China 
The Lancet Oncology 765 
24 Zou L. SARS-CoV-2 viral load in upper respiratory specimens of 
infected patients 
New England Journal of Medicine 757 
25 Rothe C. Transmission of 2019-NCOV infection from an asymptomatic 
contact in Germany 
New England Journal of Medicine 739 
26 Wang C. A novel coronavirus outbreak of global health concern The Lancet 732 
27 Ai T. Correlation of Chest CT and RT-PCR Testing for Coronavirus 
Disease 2019 (COVID-19) in China: A Report of 1014 Cases 
Radiology 692 
28 Chen H. Clinical characteristics and intrauterine vertical transmission 
potential of COVID-19 infection in nine pregnant women: a 
retrospective review of medical records 
The Lancet 676 
29 Wrapp D. Cryo-EM structure of the 2019-nCoV spike in the prefusion 
conformation 
Science 671 
30 Bai Y. Presumed Asymptomatic Carrier Transmission of COVID-19 JAMA - Journal of the American 
Medical Association 
638 
31 Wang W. Detection of SARS-CoV-2 in Different Types of Clinical 
Specimens 
JAMA - Journal of the American 
Medical Association 
636 
32 Corman V.M. Detection of 2019 novel coronavirus (2019-nCoV) by real-time 
RT-PCR 
Eurosurveillance 627 
33 Tang N. Abnormal coagulation parameters are associated with poor 
prognosis in patients with novel coronavirus pneumonia 
Journal of Thrombosis and 
Haemostasis 
626 
34 Brooks S.K. The psychological impact of quarantine and how to reduce it: 
rapid review of the evidence 
The Lancet 620 
35 Mao L. Neurologic Manifestations of Hospitalized Patients with 
Coronavirus Disease 2019 in Wuhan, China 
JAMA Neurology 582 
36 Gorbalenya 
A.E. 
The species Severe acute respiratory syndrome-related 
coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 
Nature Microbiology 578 
37 Wan Y. Receptor recognition by the novel coronavirus from Wuhan: 
An analysis based on decade-long structural studies of SARS 
coronavirus 
Journal of Virology 575 
38 Wu J.T. Nowcasting and forecasting the potential domestic and 
international spread of the 2019-nCoV outbreak originating in 
Wuhan, China: a modelling study 
The Lancet 554 
39 Gao J. Breakthrough: Chloroquine phosphate has shown apparent 
efficacy in treatment of COVID-19 associated pneumonia in 
clinical studies 
BioScience Trends 553 
40 Ruan Q. Clinical predictors of mortality due to COVID-19 based on an 
analysis of data of 150 patients from Wuhan, China 
Intensive Care Medicine 551 
41 Walls A.C. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike 
Glycoprotein 
Cell 547 
42 Shi H. Radiological findings from 81 patients with COVID-19 
pneumonia in Wuhan, China: a descriptive study 
The Lancet Infectious Diseases 544 
43 Richardson S. Presenting Characteristics, Comorbidities, and Outcomes 
among 5700 Patients Hospitalized with COVID-19 in the New 
York City Area 
JAMA - Journal of the American 
Medical Association 
542 
44 Lai C.-C. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
and coronavirus disease-2019 (COVID-19): The epidemic and 
the challenges 
International Journal of 
Antimicrobial Agents 
532 
45 Yao X. In Vitro Antiviral Activity and Projection of Optimized Dosing 
Design of Hydroxychloroquine for the Treatment of Severe 
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 
Clinical infectious diseases : an 
official publication of the 
Infectious Diseases Society of 
America 
496 
46 Dong E. An interactive web-based dashboard to track COVID-19 in real 
time 
The Lancet Infectious Diseases 490 
47 Zhang J.-J. Clinical characteristics of 140 patients infected with SARS-CoV-
2 in Wuhan, China 
Allergy: European Journal of 
Allergy and Clinical Immunology 
488 
48 Onder G. Case-Fatality Rate and Characteristics of Patients Dying in 
Relation to COVID-19 in Italy 
JAMA - Journal of the American 
Medical Association 
487 
49 Grasselli G. Baseline Characteristics and Outcomes of 1591 Patients 
Infected with SARS-CoV-2 Admitted to ICUs of the Lombardy 
Region, Italy 
JAMA - Journal of the American 
Medical Association 
473 
50 Fang L. Are patients with hypertension and diabetes mellitus at 
increased risk for COVID-19 infection? 
The Lancet Respiratory Medicine 472 
51 Wolfel R. Virological assessment of hospitalized patients with COVID-
2019 
Nature 471 
52 Russell C.D. Clinical evidence does not support corticosteroid treatment 
for 2019-nCoV lung injury 
The Lancet 463 
53 Lauer S.A. The incubation period of coronavirus disease 2019 (CoVID-19) 
from publicly reported confirmed cases: Estimation and 
application 
Annals of Internal Medicine 455 
54 Remuzzi A. COVID-19 and Italy: what next? The Lancet 440 
55 Hui D.S. The continuing 2019-nCoV epidemic threat of novel 
coronaviruses to global health-The latest 2019 novel 
coronavirus outbreak in Wuhan, China 
International Journal of Infectious 
Diseases 
432 
56 Rothan H.A. The epidemiology and pathogenesis of coronavirus disease 
(COVID-19) outbreak 
Journal of Autoimmunity 429 
57 Dong Y. Epidemiology of COVID-19 among children in China Pediatrics 422 
58 Chen T. Clinical characteristics of 113 deceased patients with 
coronavirus disease 2019: Retrospective study 
The BMJ 416 
59 Wang C. Immediate psychological responses and associated factors 
during the initial stage of the 2019 coronavirus disease 
(COVID-19) epidemic among the general population in China 
International Journal of 
Environmental Research and Public 
Health 
414 
60 Kampf G. Persistence of coronaviruses on inanimate surfaces and their 
inactivation with biocidal agents 
Journal of Hospital Infection 411 
61 Shi S. Association of Cardiac Injury with Mortality in Hospitalized 
Patients with COVID-19 in Wuhan, China 
JAMA Cardiology 409 
62 Qin C. Dysregulation of Immune Response in Patients With 
Coronavirus 2019 (COVID-19) in Wuhan, China 
Clinical infectious diseases : an 
official publication of the 
Infectious Diseases Society of 
America 
405 
63 Zheng Y.-Y. COVID-19 and the cardiovascular system Nature Reviews Cardiology 403 
64 Guo Y.-R. The origin, transmission and clinical therapies on coronavirus 
disease 2019 (COVID-19) outbreak- A n update on the status 
Military Medical Research 397 
65 Chung M. CT imaging features of 2019 novel coronavirus (2019-NCoV) Radiology 396 
66 Andersen K.G. The proximal origin of SARS-CoV-2 Nature Medicine 393 
67 Varga Z. Endothelial cell infection and endotheliitis in COVID-19 The Lancet 392 
68 Guo T. Cardiovascular Implications of Fatal Outcomes of Patients with 
Coronavirus Disease 2019 (COVID-19) 
JAMA Cardiology 390 
69 Grein J. Compassionate use of remdesivir for patients with severe 
Covid-19 
New England Journal of Medicine 379 
70 Tang N. Anticoagulant treatment is associated with decreased 
mortality in severe coronavirus disease 2019 patients with 
coagulopathy 
Journal of Thrombosis and 
Haemostasis 
379 
71 Yan R. Structural basis for the recognition of SARS-CoV-2 by full-
length human ACE2 
Science 375 
72 Shen C. Treatment of 5 Critically Ill Patients with COVID-19 with 
Convalescent Plasma 
JAMA - Journal of the American 
Medical Association 
373 
73 Chen G. Clinical and immunological features of severe and moderate 
coronavirus disease 2019 
Journal of Clinical Investigation 369 
74 Chan J.F. Genomic characterization of the 2019 novel human-
pathogenic coronavirus isolated from a patient with atypical 
pneumonia after visiting Wuhan 
Emerging Microbes and Infections 366 
75 Vaduganathan 
M. 
Renin-angiotensin-aldosterone system inhibitors in patients 
with covid-19 
New England Journal of Medicine 362 
76 Yang J. Prevalence of comorbidities and its effects in coronavirus 
disease 2019 patients: A systematic review and meta-analysis 
International Journal of Infectious 
Diseases 
356 
77 Lu X. SARS-CoV-2 infection in children New England Journal of Medicine 356 
78 Xu X.-W. Clinical findings in a group of patients infected with the 2019 
novel coronavirus (SARS-Cov-2) outside of Wuhan, China: 
Retrospective case series 
The BMJ 355 
79 Klok F.A. Incidence of thrombotic complications in critically ill ICU 
patients with COVID-19 
Thrombosis Research 352 
80 Chen Y. Emerging coronaviruses: Genome structure, replication, and 
pathogenesis 
Journal of Medical Virology 349 
81 Lu H. Outbreak of pneumonia of unknown etiology in Wuhan, China: 
The mystery and the miracle 
Journal of Medical Virology 346 
82 Lai J. Factors Associated With Mental Health Outcomes Among 
Health Care Workers Exposed to Coronavirus Disease 2019 
JAMA network open 346 
83 Fang Y. Sensitivity of chest CT for COVID-19: Comparison to RT-PCR Radiology 344 
84 Li R. Substantial undocumented infection facilitates the rapid 
dissemination of novel coronavirus (SARS-CoV-2) 
Science 344 
85 Sohrabi C. World Health Organization declares global emergency: A 
review of the 2019 novel coronavirus (COVID-19) 
International Journal of Surgery 343 
86 Liu Y. The reproductive number of COVID-19 is higher compared to 
SARS coronavirus 
Journal of Travel Medicine 343 
87 Li Y.-C. The neuroinvasive potential of SARS-CoV2 may play a role in 
the respiratory failure of COVID-19 patients 
Journal of Medical Virology 341 
88 Emanuel E.J. Fair allocation of scarce medical resources in the time of covid-
19 
New England Journal of Medicine 341 
89 Xu X. Evolution of the novel coronavirus from the ongoing Wuhan 
outbreak and modeling of its spike protein for risk of human 
transmission 
Science China Life Sciences 341 
90 Jin Y.-H. A rapid advice guideline for the diagnosis and treatment of 
2019 novel coronavirus (2019-nCoV) infected pneumonia 
(standard version) 
Military Medical Research 335 
91 Young B.E. Epidemiologic Features and Clinical Course of Patients Infected 
with SARS-CoV-2 in Singapore 
JAMA - Journal of the American 
Medical Association 
328 
92 Liu J. Hydroxychloroquine, a less toxic derivative of chloroquine, is 
effective in inhibiting SARS-CoV-2 infection in vitro 
Cell Discovery 326 
93 Bhatraju P.K. COVID-19 in critically ill patients in the Seattle region-Case 
series 
New England Journal of Medicine 326 
94 To K.K.-W. Temporal profiles of viral load in posterior oropharyngeal 
saliva samples and serum antibody responses during infection 
by SARS-CoV-2: an observational cohort study 
The Lancet Infectious Diseases 325 
95 Sheahan T.P. Comparative therapeutic efficacy of remdesivir and 
combination lopinavir, ritonavir, and interferon beta against 
MERS-CoV 
Nature Communications 321 
96 Zhang Y. Coagulopathy and antiphospholipid antibodies in patients with 
covid-19 
New England Journal of Medicine 315 
97 Zhang W. Molecular and serological investigation of 2019-nCoV infected 
patients: implication of multiple shedding routes 
Emerging Microbes and Infections 314 
98 Hollander J.E. Virtually perfect? Telemedicine for covid-19 New England Journal of Medicine 313 
99 Ong S.W.X. Air, Surface Environmental, and Personal Protective 
Equipment Contamination by Severe Acute Respiratory 
Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic 
Patient 
JAMA - Journal of the American 
Medical Association 
306 
100 Xiao F. Evidence for Gastrointestinal Infection of SARS-CoV-2 Gastroenterology 304 
 
The inter-citation network of highly cited T100 articles on Covid-19 is depicted in Figure 1. 
 
Figure 1. Represents the inter-citation networks of most cited 100 articles on covid-19 
 
 The analysis of the literature on Covid-19 shows that the China ranked top with the 
greatest number of publications (n=63) followed by United States of America (n=27) and United 
Kingdom (n=13) publications. Results indicate that the T100 cited articles were altogether 
contributed by 26 countries. Scientific publications originated from china received highest 
citations (55,688) followed by USA (13,996) and Hong Kong (9,501). Other prominent countries 
which are significantly contributed in these research studies are Hong Kong (n=10), Germany 
(n=9, citation- 5313), Netherlands (n=5, citation- 2628), Italy (n=5, citation- 2211), France(n=4, 
citation- 2480), Switzerland(n=4, citation- 1807) and Singapore(n=4, citation- 1445) . 
 
 The 100 most influential papers were scattered across 44 journals with the number of 
manuscripts per journal ranging from 1 to 15. Only 18 journals have published two or more of 
those articles whereas remaining journals are hold single publication. Journals published with 
four or more articles along with impact factor values shown in Table 2. Although ‘The New 
England Journal of Medicine’ published the most papers (n = 15), with highest impact factor of 
(74.699) but studies published in ‘The Lancet’ has received highest citations (n=18,431). The top 
five journals hold 44% of these influential studies. Most of these influential studies are published 
in well qualified journal with significant higher value of impact factor.   
Table 2. Journals with four or more articles in the top 100. 
 
Journal Title NP TC ACP JIF as of 
2019 
The New England Journal of Medicine 15 15222 1014.80 74.699 
The Lancet 13 18431 1417.77 60.392 
JAMA - Journal of the American Medical Association 10 8996 899.60 45.54 
Nature 3 3394 1131.33 42.778 
The Lancet Respiratory Medicine 3 2836 945.33 25.094 
Radiology 3 1432 477.33 7.931 
Science 3 1390 463.33 41.845 
The Lancet Infectious Diseases 3 1359 453.00 24.446 
Journal of Medical Virology 3 1036 345.33 2.021 
Cell 2 1880 940.00 38.637 
International Journal of Antimicrobial Agents 2 1459 729.50 4.621 
Journal of thrombosis and haemostasis 2 1005 502.50 4.157 
Clinical infectious diseases 2 901 450.50 8.313 
JAMA Cardiology 2 799 399.50 12.794 
International Journal of Infectious Diseases 2 788 394.00 3.202 
The BMJ 2 771 385.50 30.223 
Military Medical Research 2 732 366.00 2.325 
Emerging Microbes and Infection 2 680 340.00 5.776 
 
 The result revealed that the most publishing author Zhang I (n=6) has link strength of 285 
received 6598 citations where as Chen H has published 6 papers but his link strength of 405 is 
highest in the network. The top 5 authors with the maximum contribution and largest total link 
strength were Zhang I (TP=6, TC=6598, TLS=285), Wang W(TP=6, TC=6118, TLS=206), 
Wang Y(TP=6, TC=6045, TLS=139), Chen H (TP=6, TC=5845, TLS=405) and Drosten 
C(TP=6, TC=4180, TLS=298). Our purpose is not to rank authors; rather, we attempt to identify 
the most active researchers in order to understand their contribution towards the growth of the 
field. The cluster of author network map is displayed in Figure 2. 
 Co-occurrence of keywords analysis using VOSviewer tool is conducted and the results 
indicated the key concepts that have been explored by researchers in these 100 most-cited 
articles (Sahoo & Pandey, 2020). The research focus of these top 100 papers were found to be 
mainly clinical characteristics of the epidemic, early transmission, infection, diagnosis, 
experimental treatments and care. Results of clusterwise keywords analysis is shown in Figure 3. 
 
Discussions 
 In this study, we identify, rank and characterize the top 100 most cited research articles 
on Covid-19. The quantitative information about active authors, prominent institutions and core 
journals that published these influential studies was also provided. Usually an article received 
more citations with increasing age, and longer citable period. However, in our analysis, reveals 
that the number of research articles increased tremendously in this field in the last eight months. 
The domain has received the attention of the global scientific communities due to the magnitude 
of impact on public health and the rapid spread of the disease. COVID-19 has not only impacted 
hugely on global health, businesses but also disrupted the world economics (Haleem et al., 
2020). 
 Citation map of top 100 studies on covid-19 is depicted in Figure 1. The citations count 
of an article partly depends on the early publication of the article, as citations accumulate over 
the years. However, we observed these papers are received huge citations in a very short time. 
This unusual growth may be attributed due to the novelty of these studies and the global impact 
of the disease. Publishing in open access platform has definitely generated wider visibility of 
these works and the knowledge being shared among the global research communities actively 
engaged in covid-19 pandemic.   
 Country wise distribution analysis indicated that the China has contributed maximum 
research publications (n=63) followed by United States of America (n=27) and United Kingdom 
(n=13). Scientific publications originated from china received highest citations (55688) followed 
by USA (13996) and Hong Kong (9501). Although scientific publications originated from the 
China had received highest citations but research studies from Hong Kong received highest 
average citation per paper (950.10). Overall 26 countries together contributed to the top 100 most 
cited articles. 
 Of the total T100 articles, the leading institutions with the most productive articles were 
(Tongji medical college, Huazhong university of science and technology, Wuhan, China), (Jin 
yin-tan hospital, Wuhan, China), (Tsinghua university school of medicine, Beijing, China) and 
University of North Carolina, United States. 
 
This finding illustrates the inverse correlation between average citations per year since 
publication and article age. It was a surprise to see such a trend and phenomenal growth of 
citations for younger publications. 
  The 100 most influential papers were scattered across 44 journals with the number of 
manuscripts per journal ranging from 1 to 15. Only 18 journals published 2 or more papers 
whereas remaining 26 sources hold single publication each. Although ‘The New England Journal 
of Medicine’ published the most papers (n = 15), with highest impact factor of (74.699) but 
studies published in ‘The Lancet’ has received highest citations (n=18,431). The top five journals 
hold 44% of these influential studies. Most of these influential studies are published in well 
qualified journal with significant higher value of impact factor. The range of impact factor values 
for these sources varies from 2.021 to 74.699. 
 Authorship analysis was performed to have better understanding of research collaboration 
among the scientific community. Out of 732 authors only 127 authors having minimum 2 
publications are considered for creating cluster network and displayed in Figure 2. Each node in 
the graph presents an author, the size of the node depicts number articles the author has 
published, and the connection indicates cooperative relationship among these authors. From the 
figure, it can be seen that the most prolific authors are usually located in the core of the network 
and the distance between them is shortest. Each cluster of authors is distinguished by different 
colors code and the line shows the links strength between them. The result revealed that the most 
publishing author Zhang I (n=6) has link strength of 285 received 6598 citations where as Chen 
H has published 6 papers but his link strength of 405 is highest in the network. The top 5 authors 
with the maximum contribution and largest total link strength were Zhang I (TP=6, TC=6598, 
TLS=285), Wang W(TP=6, TC=6118, TLS=206), Wang Y(TP=6, TC=6045, TLS=139), Chen H 
(TP=6, TC=5845, TLS=405) and Drosten C(TP=6, TC=4180, TLS=298). 
 
Figure 2. Represent network map of prominent authors based on their citations values and link strength 
   
 Co-occurrence of keywords analysis was conducted to find out the key concepts that have 
been explored by the researchers in these 100 most-cited articles. This was done by analyzing the 
data using VOSviewer application tool, and the results are shown in Figure 3. A minimum 
occurrence of 5 or more is fixed and only 185 keywords are qualified for generating the network 
map. These key terms are grouped in to 4 clusters distinguished by different color. It has been 
found that, the most repeated keyword (frequency = 84) in cluster-3 is ‘coronavirus infection’ 
with link strength 2078. This particular keyword has strong associations with ‘human’ 
(frequency = 81) in cluster-2 and ‘China’ (frequency = 63) of cluster-3 and also with ‘virus 
pneunomia’ (frequency = 62) of cluster-4. As seen from Figure 3 the second, third and four 
clusters are positioned close to each other in the network while at the same time first cluster is 
little far away. This reveals the close and strong association between the keywords in these 2, 3 
& 4 clusters compared with the cluster-1 depicting the origin and nature of the epidemic & 
humans are the most affected by Covid-19 disease. It is also observed that much of these works 
are focus on the virus origin, infection prevention and control, pathological findings and clinical 
aspects of disease & no much research attention was drawn towards potential drugs to control the 
epidemic. 
 
Figure 3. Represent the Keyword clusters map based on their influences & occurrences 
 Conclusions 
 In the current study, we summarized most of the influential studies on Covid-19 based on 
top citations, and highlights research areas that require further investigation. Our analysis 
provides an insight into the top-cited research articles on Covid-19(SARS-COV-2) and 
highlights the impact of the studies, discoveries and global research trends. China has 
contributed maximum influential research publications followed by United States of America 
and United Kingdom. Scientific publications originated from the China also had the highest 
mean number of citations. The leading institutions with the most productive articles were Tongji 
medical college, Jin yin-tan hospital, Tsinghua university school of medicine (China) and 
University of North Carolina (USA). The study authored by Huang C on “Clinical features of 
patients infected with 2019 novel coronavirus in Wuhan, China” has received maximum citations 
of 5,295. The study presented an outlook to T100 top research papers which is limited to the 
citation data extracted from Scopus database. Future studies may be conducted by considering 
other citation databases like PubMed, WoS and Dimesion Data. An altemtrics study may be 
carried out to see the correlation between citation and altemtrics score. Study revealed several 
interesting findings and results of the study may be taken as pointer for the further bibliometric 
study on SARS-COV-2. 
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